Page last updated: 2024-08-16

thalidomide and oblimersen

thalidomide has been researched along with oblimersen in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badros, AZ; Fenton, RG; Flaws, JA; Gahres, N; Gocke, CD; Goloubeva, O; Heyman, M; Meisenberg, B; Rapoport, AP; Ratterree, B; Streicher, H; Takebe, N; Tomic, D; Zhang, B; Zwiebel, J	1
Chon, HS; Hu, W; Kavanagh, JJ	1
Lin, TS	1

Reviews

2 review(s) available for thalidomide and oblimersen

Article	Year
Targeted therapies in gynecologic cancers. Current cancer drug targets, 2006, Volume: 6, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gefitinib; Gene Transfer Techniques; Genital Neoplasms, Female; Humans; Neovascularization, Pathologic; Oligonucleotides, Antisense; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Receptor, ErbB-2; Signal Transduction; Thalidomide; Thionucleotides; Trastuzumab	2006
Novel agents in chronic lymphocytic leukemia: efficacy and tolerability of new therapies. Clinical lymphoma & myeloma, 2008, Volume: 8 Suppl 4 Topics: Antineoplastic Agents; Bendamustine Hydrochloride; Flavonoids; Humans; Indoles; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Maximum Tolerated Dose; Nitrogen Mustard Compounds; Piperidines; Pyrroles; Thalidomide; Thionucleotides; Treatment Outcome	2008

Article

Year

Targeted therapies in gynecologic cancers.

Current cancer drug targets, 2006, Volume: 6, Issue:4

Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gefitinib; Gene Transfer Techniques; Genital Neoplasms, Female; Humans; Neovascularization, Pathologic; Oligonucleotides, Antisense; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Receptor, ErbB-2; Signal Transduction; Thalidomide; Thionucleotides; Trastuzumab

2006

Novel agents in chronic lymphocytic leukemia: efficacy and tolerability of new therapies.

Clinical lymphoma & myeloma, 2008, Volume: 8 Suppl 4

Topics: Antineoplastic Agents; Bendamustine Hydrochloride; Flavonoids; Humans; Indoles; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Maximum Tolerated Dose; Nitrogen Mustard Compounds; Piperidines; Pyrroles; Thalidomide; Thionucleotides; Treatment Outcome

2008

Trials

1 trial(s) available for thalidomide and oblimersen

Article	Year
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-20, Volume: 23, Issue:18 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Dexamethasone; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Oligonucleotides, Antisense; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Stem Cell Transplantation; Survival Analysis; Thalidomide; Thionucleotides; Treatment Outcome	2005

Article

Year

Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-20, Volume: 23, Issue:18

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Dexamethasone; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Oligonucleotides, Antisense; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Stem Cell Transplantation; Survival Analysis; Thalidomide; Thionucleotides; Treatment Outcome

2005